[昆卡州公立幼儿园的微气候及其与过敏性鼻炎的关系,2021]
Paola Belén Delgado-Palacios1, Angelica Ochoa-Avilés2, María José Molina3
1Universidad del Azuay, Ecuador. belendelgadopal@gmail.com.
概括
这项研究发现,在库恩卡的学龄前儿童中,教室湿度/温度和过敏性鼻炎 (AR) 之间没有联系. 在分析条件下,环境因素没有影响AR呈现.
科学领域:
- 环境健康 环境健康
- 儿科过敏 儿科过敏
- 流行病学 流行病学
背景情况:
- 过敏性鼻炎 (AR) 是一种慢性IgE介导的鼻炎.
- 了解湿度和温度等环境影响对于儿童AR发育至关重要.
- 这项研究的重点是昆卡市公立学校的学龄前儿童.
研究的目的:
- 研究课堂微气候因素 (湿度,温度) 与学前学生过敏性鼻炎患病率之间的关联.
- 分析非舒适温度和湿度范围对AR呈现的影响.
主要方法:
- 追溯病例控制研究涉及351名学龄前儿童 (3-5岁) 来自库恩卡的16个公共机构.
- 使用了国际儿童喘和过敏研究 (ISAAC) 关于AR患病率的问卷,并收集了课堂气候数据.
- 采用几率比率统计方法来确定AR和环境变量之间的关联.
主要成果:
- 千平方测试显示,在舒适度范围之外的相对湿度和温度与学龄前儿童过敏鼻炎的存在之间没有统计学上显著的关联.
- 研究的微气候变量与AR发生率之间没有发现相关性.
结论:
- 该研究得出的结论是,在分析条件下,湿度和温度不会显著影响昆卡学龄前儿童过敏性鼻炎的表现.
- 可能需要进一步的研究,以探索其他潜在的贡献因素,在这个人群中AR.
更多相关视频
相关概念视频
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Allergic Reactions
31.9K
Overview
31.9K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
904
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
904
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K


